Univest
Univest
  • Markets

Amanta Healthcare (AMANTA) Share Price Rises 9.17% to Rs 240.45 Today

  • November 17, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Amanta Healthcare Share Price
Amanta Healthcare Ltd. (AMANTA) share price rose to Rs 240.45 today, up 9.17% from the previous close. Market cap was Rs 855.22 crore.

The Amanta Healthcare Share Price stood at Rs 240.45 as of 17 November 2026 at 10:52:39 AM IST, a gain of Rs 20.20 or 9.17% over the previous close of Rs 220.25. The company carries a market capitalisation of Rs 855.22 crore, and the stock features among the Stocks Rising Today in the Indian Stock Market, with Amanta Healthcare NSE and BSE quotes both reflecting the move.

This Amanta Healthcare Share Price Rise is a same-day price move. The price move is confirmed in Univest data; a company-specific reason has not been established. What the latest Univest figures do show is a stock that opened at Rs 220.25, touched a low of Rs 218.80 and reached a high of Rs 243.10 during the morning.

Table of Contents

Toggle
  • Amanta Healthcare Share Price Today: Price Action Analysis
  • Amanta Healthcare Ltd. (AMANTA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Amanta Healthcare
  • About Amanta Healthcare
  • Frequently Asked Questions
    • How much has the Amanta Healthcare Share Price risen today?
    • Why is the Amanta Healthcare Share Price rising today?
    • What is the market capitalisation of Amanta Healthcare?
    • What is the P/E ratio of Amanta Healthcare?
    • What are the ROE and ROCE of Amanta Healthcare?
    • What are the EPS and book value of Amanta Healthcare?
    • How does Amanta Healthcare compare with its peers?
  • Track Amanta Healthcare Share Price on Univest

Amanta Healthcare Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 240.45
Previous Close Rs 220.25
Today's Move Rs 20.2 (+9.17%)
Open Rs 220.25
High Rs 243.1
Low Rs 218.8
Market Capitalisation Rs 855.22 crore
Market Cap Category Micro Cap

Amanta Healthcare Ltd. (AMANTA) rose to Rs 240.45 from the previous close of Rs 220.25, a move of Rs 20.2 or 9.17%. The stock opened at Rs 220.25, reached a high of Rs 243.1, recorded a low of Rs 218.8.

The Amanta Healthcare Share Price Today is Rs 240.45, up Rs 20.20 or 9.17% from the previous close of Rs 220.25. The stock opened at Rs 220.25 and has moved between Rs 218.80 and Rs 243.10 so far, with the last traded price sitting just below the day’s high.

The session range runs from a low of Rs 218.80 to a high of Rs 243.10, and the last traded price of Rs 240.45 is near the upper end of that range. The opening level of Rs 220.25 matched the previous close exactly, so the Amanta Healthcare Share Price began the day flat before reaching its current level.

Amanta Healthcare Stock Performance today therefore reads as a gain of 9.17% on a market capitalisation of Rs 855.22 crore. Price Action on its own does not explain the reason for the move, so the next step is to check whether fundamentals add context, which the following section covers.

Amanta Healthcare Ltd. (AMANTA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 855.22 crore
P/E Ratio 46.65x
P/B Ratio 3.75x
ROE 9.4%
ROCE 11.23%
EPS Rs 4.72
Book Value Per Share Rs 58.75
Dividend Yield 0%

Amanta Healthcare Ltd. (AMANTA) fundamental metrics show P/E 46.65x, P/B 3.75x, ROE 9.4%, ROCE 11.23%. These ratios show where the company stands today and are not a call to buy or sell.

Amanta Healthcare Ltd. has a market capitalisation of Rs 855.22 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46.65x, P/B at 3.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.4% and ROCE of 11.23%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.72, book value per share of Rs 58.75, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.46x, median ROE of 11.33%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 46.65x
Benchmark Median P/E 30.46x
Benchmark Average P/E 52.1x
Benchmark P/E Range 2.82x to 1,227.27x
Company P/B Ratio 3.75x
Benchmark Median P/B 2.92x
Company ROE 9.4%
Benchmark Median ROE 11.33%
Company ROCE 11.23%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 855.22 crore
Benchmark Median Market Cap Rs 760.34 crore

Amanta Healthcare Ltd. (AMANTA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Amanta Healthcare Ltd. (AMANTA) has a P/E ratio of 46.65x, which is above the benchmark median of 30.46x, a difference of +53.15%. A P/E difference of this kind is a reference point rather than a recommendation.

Amanta Healthcare Ltd. (AMANTA) has a ROE of 9.4%, which is below the benchmark median of 11.33%, a difference of -17.03%. Amanta Healthcare Ltd. (AMANTA) has a ROCE of 11.23%, which is below the benchmark median of 13.1%, a difference of -14.27%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 40.85 5.02 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 87.71 16.39 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.99 9.71 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 89.4 19.77 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.37 4.26 19.69 21.39

Amanta Healthcare Ltd. (AMANTA) has a P/E ratio of 46.65x compared with the displayed peer median of 83.99x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.4% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.23% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Amanta Healthcare Ltd. (AMANTA) has a market capitalisation of Rs 855.22 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Amanta Healthcare

Investors are watching Amanta Healthcare because the verified data shows a 9.17% price rise alongside valuation and return figures that can be set against the Pharmaceuticals & Drugs industry benchmark and five listed peers. The points below summarise what the latest Univest figures establish.

  • Price move: the Amanta Healthcare Share Price rose 9.17% to Rs 240.45 against a previous close of Rs 220.25.
  • Day range: the stock has moved between Rs 218.80 and Rs 243.10 and last traded near the high.
  • Valuation: a P/E ratio of 46.65 compares with an industry median of 30.46.
  • Returns: ROE of 9.40% sits above the benchmark average of 5.24%, while ROCE of 11.23% sits below the median of 13.10%.
  • Peers: the market capitalisation of Rs 855.22 crore is the smallest among the five peers listed.

About Amanta Healthcare

Amanta Healthcare Ltd. trades under the symbol AMANTA and is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry on Univest. Its market capitalisation of Rs 855.22 crore places it inside a same-industry benchmark of 200 companies, where the median market capitalisation is Rs 760.34 crore and the largest company reaches Rs 4,51,290.91 crore.

The company reports EPS of Rs 4.72 and book value per share of Rs 58.75, with a dividend yield of 0%. Investors who want fuller business details, segments and products can read the company’s own exchange filings alongside this Company Overview.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

How much has the Amanta Healthcare Share Price risen today?

Ans. The Amanta Healthcare Share Price has risen by Rs 20.20, or 9.17%, to Rs 240.45 so far. The stock opened at Rs 220.25 and has moved between a low of Rs 218.80 and a high of Rs 243.10 during the morning.

Why is the Amanta Healthcare Share Price rising today?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. What the figures show is a 9.17% gain to Rs 240.45 and a P/E ratio of 46.65 against an industry median of 30.46.

What is the market capitalisation of Amanta Healthcare?

Ans. Amanta Healthcare has a market capitalisation of Rs 855.22 crore. Within the same-industry benchmark of 200 companies, the median is Rs 760.34 crore and the average is Rs 14,899.39 crore, so the company sits above the median but below the average.

What is the P/E ratio of Amanta Healthcare?

Ans. The P/E ratio of Amanta Healthcare is 46.65, alongside a P/B ratio of 3.75. The Pharmaceuticals & Drugs benchmark shows a median P/E ratio of 30.46 and a median P/B ratio of 2.92, so both multiples sit above the benchmark medians.

What are the ROE and ROCE of Amanta Healthcare?

Ans. Amanta Healthcare reports ROE of 9.40% and ROCE of 11.23%. Both sit below the industry medians of 11.33% and 13.10%, and below all five listed peers compared on Univest, where the lowest ROE is 14.85% and the lowest ROCE is 18.20%.

What are the EPS and book value of Amanta Healthcare?

Ans. EPS is Rs 4.72, which shows the earnings attributable to each share, and book value per share is Rs 58.75, which shows the accounting net worth behind each share. The Amanta Healthcare Share Price of Rs 240.45 is a multiple of both figures.

How does Amanta Healthcare compare with its peers?

Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences, Amanta Healthcare shows the lowest P/B ratio at 3.75, the lowest ROE at 9.40% and the smallest market capitalisation at Rs 855.22 crore.

Track Amanta Healthcare Share Price on Univest

Use Amanta Healthcare Ltd. (AMANTA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track the live Amanta Healthcare Share Price, fundamental ratios, 52-week levels and market insights on Univest. Univest also carries Market Update coverage of other Top Gainers Today.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply